The safety of liraglutide (and exenatide) can only truly be assessed with robust phase IV postmarketing data involving long-term treatment with this novel therapy
Long-Acting GLP-1 RAs Exenatide (Bydureon) In 1987, scientists discovered that GLP-1 promotes insulin secretion, and five years later, an entero-insulin analogue, Exendin-4, which is 53% homologous to GLP-1, was isolated from the saliva of the Mexican giant lizard, later known as exenatide, which has GLP-1 receptor agonist activity and a half-life of 2.4 hours
Thus, due to the activity of DPP-4 only 1015% of secreted GLP-1 reaches circulation intact
Talk to your healthcare provider about which one may be right for you
Bydureon was a once-weekly subcutaneous injectable extended-release suspension of exenatide that was approved for type 2 diabetes
Common side effects of Mounjaro include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and/or stomach pain